$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Head and neck cancers originate from the oral cavity, pharynx, sinonasal tract, salivary glands, skin and larynx1. These malignancies rank in the top ten most common cancers, accounting for approximately 70,000 new diagnoses and 16,000 deaths annually in the United States, and 900,000 new diagnoses and 450,000 deaths worldwide2,3. Head and neck cancer treatment often requires long-term multispecialty and multimodality care4,5. Primary surgical resection followed by adjuvant radiation (RT) or chemoradiation (CRT) is recommended for most advanced stage cancers arising in the oral cavity, salivary glands, sinonasal cavities, larynx, and hypopharynx 6. Surgery remains the most effective treatment modality7. Prior research has demonstrated a significant survival benefit over definitive RT or CRT in oral cavity, HPV-negative oropharyngeal, early supraglottic, and advanced-stage laryngeal cancers8,9,10,11,12.
The goal of surgical resection is to achieve tumor clearance documented as negative margins13. The status of the surgical margin is an independent prognostic factor that predicts recurrence, as well as the need for further treatment14. Positive margins have been linked to decreased survival, increased local recurrence, increased cost of care, and treatment intensification15. Intraoperative frozen section analysis remains the best practice for achieving tumor clearance and is widely employed by head and neck surgeons to help guide intraoperative decision making and the harvest of additional tissue during surgery16. Oncologic frozen section margin analysis involves analyzing tissue samples that are traditionally harvested from the resected specimen (specimen-driven) or from the tumor bed (defect-driven), the former of which is associated with superior rates of local control17,18,19,20,21. However, this process has remained stagnant and unstandardized, with variable surgical approaches, communication strategies, and definitions of margin clearance17,22. Information about the location and breadth of margins "at-risk" (<5 mm or positive) guides the harvest of additional tissue - and the pursuit of tumor clearance. However, surgeons and pathologists often rely on informal, undocumented conversations and crude two-dimensional drawings for communication23. There is ample room for improvement; prior investigations found that supplemental margins can be off-target by as much as 1 cm in one-third of cases24.
The surgical pathology report serves to convey the pathological information gathered during surgery and guide postoperative decision-making. Prior research has demonstrated that the pathology report lacks clarity and is often misinterpreted. Powsner et al. reported a 30% misinterpretation rate of pathology reports among surgeons25. Mossanen et al. reviewed several articles examining the clarity of surgical pathology reports and identified calls for standardization and clearer organization26. In a survey of head and neck cancer specialists, respondents reported a lack of clarity regarding whether supplemental margins reflected tumor clearance, the extent of supplemental margins harvested intraoperatively, and the final margin status. Most radiation and medical oncologists (61%) found pathology reports difficult to navigate and reported that critical information is not easily accessible27. These findings emphasize the need to improve final pathology reports to ensure that postoperative providers have access to accurate, detailed information essential for optimizing care.
Given the prognostic importance of the surgical margin, it is particularly concerning that the final margin status is not made clear in pathology reports. We believe that the process of intraoperative pathologic consultation represents a modifiable target for improving the clarity of the surgical pathology report. We have spent several years identifying and implementing actionable changes in intraoperative pathologic consultation and reporting for head and neck cancer22,23,28,29. We have published in detail aboutĀ 3D optical scanning of both the surgical specimen and ablative defect23,28. In tandem with our established 3D scanning method, we have implemented a series of structured, intraoperative "timeouts" to standardize and improve surgeon-pathologist communication during oncologic resections. We have also developed a novel pathologic reporting software, MarginView3D (MV3D), that facilitates this approach. Here, we outline an intraoperative workflow designed to improve communication and create a clear and definitive surgical pathology report. This approach can be utilized in any head and neck cancer resection for which frozen section analysis is the standard of care. It is anticipated that it will be useful in other forms of surgical oncology that utilize frozen section analysis.